Dr. Federico Badalà is a USA trained eye surgeon who established his reputation in Italy introducing innovative eye laser and treatments in the field of cornea, cataract, glaucoma and maculopathy.
Thanks to his contribution to ophthalmology, he was selected in 2007 as scientific coordinator of the American Journal of Ophthalmology, one of the most influential scientific newspaper in Ophthalmology.
In 2008, Dr. Badalà has been the first ophthtalmologist in Italy to ever implant artificial cornea: “Boston Keratoprosthesis”.
In 2009, he’s nominated among the most important ocular microsurgery experts from the Who’s Who in Healthcare & Medicine organisation in the USA.
In January 2010, he’s the first surgeon in Italy to perform cataract surgery using intraocular lenses customizable with light.
In 2013, he introduced in Milan the new corneal transplant non-invasive, called DMEK (Descemet Membrane Endothelial Keratoplasty).
He regularly helds courses on corneal transplant surgery, innovations on cataract surgery and refractive surgery, on behalf of the most important scientific society such as the American Academy of Ophthalmology and the European Society of Cataract and Refractive Surgery -ESCRS.
Dr. Federico Badalà starts his experience in medicine in 1999, when he graduates in medicine and surgery at the University of Catania with full marks and honors.
During the same year, he starts his Opthalmology Residency at University of Genoa, where he graduates with full marks and honors in 2003.
At the same time, he gets licensed as a doctor in the USA, brilliantly passing the exams (Step1, Step 2, Step 3 and CSA) of the United States Medical Licensing Examination (USMLE): he now can fully practise medicine and surgery in the USA.
In 2004 he starts working as Visiting Assistant Professor at the Jules Stein Eye Institute of the University of California Los Angeles (UCLA), one of the most prestigious University Eye Hospital in the USA. Under the guide of Professor Joseph Caprioli, he achieves the title of International Fellow in Glaucoma in 2005, specialising in surgical therapies and glaucoma laser.
Next, he moves to Philadelphia to the Wills Eye University Hospital, that is one of the top three Ophthalmology Institutes in the USA (2005-2006). here he completes his training with a clinic Fellowship on cornea surgery and Refractive Surgery.
He also learns the most innovative laser surgery techniques for refractive surgery (correction of myopia, hypermetropia, astigmatism and presbyopia) and the new techniques for corneal transplant, such as the endotheliumm transplant (DSAEK) and the anterior stromal transplant (DALK).
In 2007 he’s one of the pioneers for the development of intraocular lenses to correct presbyopia. He works together with Professor Arturo Chayet (CODET Vision Institute) to study on cataract surgery with the implant of intraocular lenses, customizable with light (LAL).
He’s particularly focused on the use of these lenses to correct presbyopia.
He’s the author of more than fifty publications and international presentations about maculopathy, cataract and innovative surgery for corneal transplant. He currently works in Milan, Rome and Catania.
In 2014, he was the first surgeon to implant the new IOL AMD telescopic intraocular lens in Italy, which won the award for the best innovation in ophthalmology (The Ophthalmologist p. 26). In 2016, he introduced the first intraocular lenses with an enlarged field of vision in Italy: the EyeMax intraocular lenses. For his contribution to the development of these lenses, he is appointed as a member of the scientific advisory board of LEH Pharma, the manufacturer of EyeMax lenses.
In 2018, he received the prestigious American Academy of Ophthalmology (the scientific society of American ophthalmologists) ‘Achievement Award‘ for his contribution to ophthalmology.
He is the author of more than fifty publications and international presentations in the field of maculopathy, cataract and innovative corneal transplant surgery. He currently works in Milan and Catania.